213 related articles for article (PubMed ID: 20699370)
1. CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium.
Takakura Y; Hinoi T; Oue N; Sasada T; Kawaguchi Y; Okajima M; Akyol A; Fearon ER; Yasui W; Ohdan H
Cancer Res; 2010 Sep; 70(17):6767-78. PubMed ID: 20699370
[TBL] [Abstract][Full Text] [Related]
2. Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.
Koh I; Hinoi T; Sentani K; Hirata E; Nosaka S; Niitsu H; Miguchi M; Adachi T; Yasui W; Ohdan H; Kudo Y
Cancer Med; 2016 Jul; 5(7):1546-55. PubMed ID: 27060927
[TBL] [Abstract][Full Text] [Related]
3. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia.
Hinoi T; Lucas PC; Kuick R; Hanash S; Cho KR; Fearon ER
Gastroenterology; 2002 Nov; 123(5):1565-77. PubMed ID: 12404231
[TBL] [Abstract][Full Text] [Related]
4. CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium.
Hinoi T; Gesina G; Akyol A; Kuick R; Hanash S; Giordano TJ; Gruber SB; Fearon ER
Gastroenterology; 2005 Apr; 128(4):946-61. PubMed ID: 15825077
[TBL] [Abstract][Full Text] [Related]
5. Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells.
Hinkel I; Duluc I; Martin E; Guenot D; Freund JN; Gross I
Gastroenterology; 2012 Apr; 142(4):875-885.e3. PubMed ID: 22202456
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy.
Lee TB; Park JH; Min YD; Kim KJ; Choi CH
BMC Gastroenterol; 2008 Aug; 8():33. PubMed ID: 18673531
[TBL] [Abstract][Full Text] [Related]
7. Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer.
Naito Y; Oue N; Hinoi T; Sakamoto N; Sentani K; Ohdan H; Yanagihara K; Sasaki H; Yasui W
PLoS One; 2012; 7(11):e47545. PubMed ID: 23133598
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
10. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2.
Modica S; Morgano A; Salvatore L; Petruzzelli M; Vanier MT; Valanzano R; Esposito DL; Palasciano G; Duluc I; Freund JN; Mariani-Costantini R; Moschetta A
Gut; 2009 Sep; 58(9):1250-9. PubMed ID: 19221108
[TBL] [Abstract][Full Text] [Related]
11. Silencing of CDX2 expression in colon cancer via a dominant repression pathway.
Hinoi T; Loda M; Fearon ER
J Biol Chem; 2003 Nov; 278(45):44608-16. PubMed ID: 12947088
[TBL] [Abstract][Full Text] [Related]
12. CDX transcription factors positively regulate expression of solute carrier family 5, member 8 in the colonic epithelium.
Kakizaki F; Aoki K; Miyoshi H; Carrasco N; Aoki M; Taketo MM
Gastroenterology; 2010 Feb; 138(2):627-35. PubMed ID: 19900445
[TBL] [Abstract][Full Text] [Related]
13. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2.
Funakoshi S; Ezaki T; Kong J; Guo RJ; Lynch JP
Mol Cancer Res; 2008 Sep; 6(9):1478-90. PubMed ID: 18819935
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic PITX2 facilitates tumor cell drug resistance by inverse regulation of hOCT3/SLC22A3 and ABC drug transporters in colon and kidney cancers.
Lee WK; Thévenod F
Cancer Lett; 2019 May; 449():237-251. PubMed ID: 30742940
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.
Ding Z; Yang L; Xie X; Xie F; Pan F; Li J; He J; Liang H
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1697-707. PubMed ID: 20217131
[TBL] [Abstract][Full Text] [Related]
17. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa--with special emphasis on participation in intestinal metaplasia of the human stomach.
Mizoshita T; Inada K; Tsukamoto T; Kodera Y; Yamamura Y; Hirai T; Kato T; Joh T; Itoh M; Tatematsu M
Gastric Cancer; 2001; 4(4):185-91. PubMed ID: 11846061
[TBL] [Abstract][Full Text] [Related]
18. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells.
Domon-Dell C; Wang Q; Kim S; Kedinger M; Evers BM; Freund JN
Gut; 2002 Apr; 50(4):525-9. PubMed ID: 11889074
[TBL] [Abstract][Full Text] [Related]
20. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
Ludwig JA; Szakács G; Martin SE; Chu BF; Cardarelli C; Sauna ZE; Caplen NJ; Fales HM; Ambudkar SV; Weinstein JN; Gottesman MM
Cancer Res; 2006 May; 66(9):4808-15. PubMed ID: 16651436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
